Roivant Sciences (ROIV) Return on Sales (2020 - 2025)
Roivant Sciences' Return on Sales history spans 6 years, with the latest figure at 25.63% for Q3 2025.
- For Q3 2025, Return on Sales rose 3526.0% year-over-year to 25.63%; the TTM value through Sep 2025 reached 25.63%, up 2608.0%, while the annual FY2025 figure was 12.84%, 2248.0% up from the prior year.
- Return on Sales reached 25.63% in Q3 2025 per ROIV's latest filing, up from 18.13% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 36.26% in Q4 2024 to a low of 81.91% in Q2 2022.
- Average Return on Sales over 5 years is 11.08%, with a median of 13.07% recorded in 2021.
- Peak YoY movement for Return on Sales: crashed -6885bps in 2022, then soared 6675bps in 2023.
- A 5-year view of Return on Sales shows it stood at 12.57% in 2021, then crashed by -79bps to 22.57% in 2022, then surged by 83bps to 3.76% in 2023, then soared by 1064bps to 36.26% in 2024, then fell by -29bps to 25.63% in 2025.
- Per Business Quant, the three most recent readings for ROIV's Return on Sales are 25.63% (Q3 2025), 18.13% (Q2 2025), and 17.36% (Q1 2025).